489 results on '"Kamura Toshiharu"'
Search Results
52. Molecular pathology of atypical polypoid adenomyoma of the uterus
53. Irinotecan (CPT-11) and cisplatin as first-line chemotherapy in advanced ovarian cancer.
54. Effect of Gn-Rh agonist on cisplatin induced ovarian toxicity in rats-an experimental analysis.
55. Clinical characteristics of clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy
56. Histopathological factors influencing pelvic lymph node metastases in two or more sites in patients with cervical carcinoma undergoing radical hysterectomy
57. The grading of lymphovascular space invasion in endometrial carcinoma
58. Is nuclear expression of Y box-binding protein-1 a new prognostic factor in ovarian serous adenocarcinoma?
59. Angiogenesis in adenocarcinoma of the uterine cervix
60. Angiogenesis in endometrial carcinoma
61. A novel tumor-associated antigen expressed in human uterine and ovarian carcinomas
62. Prognostic Factors of Stage IV Epithelial Ovarian Cancer: A Multicenter Retrospective Study
63. Management of lymph nodes in the treatment of gynecologic cancers
64. Multivariate analysis of the histopathologic prognostic factors of cervical cancer in patients undergoing radical hysterectomy
65. Ovarian Endometriosis Associated with Ovarian Carcinoma: A Clinicopathological and Immunohistochemical Study
66. Race and nodal disease status are prognostic factors in patients with stage IVB cervical cancer
67. Prognostic Significance of Epithelial–Stromal Vascular Cuffing and Microvessel Density in Squamous Cell Carcinoma of the Uterine Cervix
68. Predicting Pelvic Lymph Node Metastasis in Endometrial Carcinoma
69. Comparison of p53, Ki-67, and CD44v6 Expression between Primary and Matched Metastatic Lesions in Ovarian Cancer
70. Endometrial Carcinoma Associated with Hyperplasia— Immunohistochemical Study of Angiogenesis and p53 Expression
71. A randomized phase III trial of cisplatin with or without S-1 in patients with FIGO IVB, recurrent, or persistent cervical cancer: An Asian study.
72. Enhancement of humoral and cell mediated immune response to HPV16 L1-derived peptides subsequent to vaccination with prophylactic bivalent HPV L1 virus-like particle vaccine in healthy females
73. Paclitaxel Plus Carboplatin Versus Paclitaxel Plus Cisplatin in Metastatic or Recurrent Cervical Cancer: The Open-Label Randomized Phase III Trial JCOG0505
74. Administration of standard-dose BEP regimen (bleomycin+etoposide+cisplatin) is essential for treatment of ovarian yolk sac tumour
75. Assessment of MR Imaging as a Tool to Differentiate between the Major Histological Types of Uterine Sarcomas
76. Outcomes of Single Port Laparoscopically Assisted Vaginal Hysterectomy
77. Changes in the nitric oxide-soluble guanylate cyclase system and natriuretic peptide receptor system in placentas of pregnant Dahl salt-sensitive rats
78. Radiation effects on DNA content of cervical cancer cells: A rapid evaluation of radiation sensitivity by laser scanning cytometry
79. A cohort study of gastric-type adenocarcinoma (GAS) of the uterine cervix: Multi-institutional study by Gynecologic Cancer Study Group of the Japan Clinical Oncology Group (JCOG).
80. Feasibility study of personalized peptide vaccination for recurrent ovarian cancer patients
81. Prognosis of Pregnant Women with One Abnormal Value on 75g OGTT
82. Prevention of lymphocele development in gynecologic cancers by the electrothermal bipolar vessel sealing device
83. Status of treatment for the overall population of patients with stage IVb endometrial cancer, and evaluation of the role of preoperative chemotherapy: A retrospective multi-institutional study of 426 patients in Japan
84. RECQL1 DNA Repair Helicase: A Potential Therapeutic Target and a Proliferative Marker against Ovarian Cancer
85. Phase II trial of oral etoposide plus IV irinotecan for patients with platinum-resistant and taxane-pretreated ovarian cancer (JCOG0503).
86. Acute onset autoimmune hepatitis in pregnancy complicated with fetal ascites: A case report
87. A study of the outcomes of laparoscopic surgery performed at our institution.
88. Concurrent chemoradiotherapy with low-dose daily cisplatin for high risk uterine cervical cancer: a long-term follow-up study
89. Fetomaternal hemorrhage with intraplacental chorioangioma
90. Nuclear Y-box binding protein-1 expression as a prognostic marker and correlation with epidermal growth factor receptor expression in cervical cancer.
91. Glucose transporter-1 (GLUT-1) expression in endometrial lesions
92. Controversies surrounding type III radical abdominal hysterectomy and its procedure using new instruments
93. Docetaxel/irinotecan combination chemotherapy in platinum/taxane-refractory and -resistant ovarian cancer: JGOG/WJGOG Intergroup Study
94. Precise evaluation of chemotherapy-induced peripheral neuropathy using the visual analogue scale: a quantitative and comparative analysis of neuropathy occurring with paclitaxel–carboplatin and docetaxel–carboplatin therapy
95. Diffusion-weighted MR imaging in gynecologic cancers
96. A case of minimal uterine serous carcinoma with distant lymph node metastasis without peritoneal dissemination
97. Outcomes of Fertility-Sparing Surgery for Stage I Epithelial Ovarian Cancer: A Proposal for Patient Selection
98. Asian society of gynecologic oncology workshop 2010
99. Overview on the 1st International Workshop on Gynecologic Oncology
100. Clinicopathological significance of cervical adenocarcinoma associated with lobular endocervical glandular hyperplasia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.